CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
2.040
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:03 AM EST
CytomX Therapeutics Employees
CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or 42.98% compared to the previous year. That makes CytomX Therapeutics the 33,580th largest employer in the world and 4,399th in the United States.
Employees
69
Change (1Y)
-52
Growth (1Y)
-42.98%
Revenue / Employee
$203,304
Profits / Employee
-$1,281,507
Market Cap
444.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | -52 | -42.98% | 69 | 0 |
| Dec 31, 2024 | 121 | -1 | -0.82% | 119 | 2 |
| Dec 31, 2023 | 122 | 4 | 3.39% | 120 | 2 |
| Dec 31, 2022 | 118 | -60 | -33.71% | 116 | 2 |
| Dec 31, 2021 | 178 | 32 | 21.92% | 174 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 625 |
| Arvinas | 246 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
| Oculis Holding AG | 60 |
| Shattuck Labs | 40 |
| DiaMedica Therapeutics | 35 |
CTMX News
- 3 days ago - CytomX Therapeutics price target raised to $12 from $11 at JPMorgan - TheFly
- 6 days ago - CytomX Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 9 days ago - CytomX Therapeutics price target raised to $12 from $11 at Wedbush - TheFly
- 10 days ago - CytomX Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - CytomX Therapeutics Quarterly report: Q3 2026 - Filings
- 10 days ago - CytomX Therapeutics Earnings release: Q3 2026 - Filings
- 10 days ago - CytomX Therapeutics reports Q3 EPS (9c), consensus (7c) - TheFly
- 10 days ago - CytomX Therapeutics announces cash runway into 2H of 2028 - TheFly